Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$7.55 - $11.25 $1,600 - $2,385
212 New
212 $3,000
Q3 2021

Oct 06, 2021

SELL
$11.73 - $16.08 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$12.85 - $16.2 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

SELL
$13.84 - $17.8 $1,384 - $1,780
-100 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$9.31 - $21.24 $931 - $2,124
100 New
100 $1,000
Q4 2019

Jan 17, 2020

BUY
$13.91 - $21.48 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$15.84 - $30.01 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

SELL
$9.2 - $21.21 $691,766 - $1.59 Million
-75,192 Closed
0 $0
Q4 2018

Jan 23, 2019

BUY
$9.61 - $14.02 $703,567 - $1.03 Million
73,212 Added 3697.58%
75,192 $0
Q3 2018

Oct 25, 2018

BUY
$8.1 - $13.6 $12,960 - $21,760
1,600 Added 421.05%
1,980 $0
Q2 2018

Aug 07, 2018

BUY
$11.2 - $15.0 $4,256 - $5,700
380 New
380 $0

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $288M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.